Use of {99m}Tc-HMPAO in Evaluating the Results of Cerebral Hypoperfusion Prevention in the Patients with Coronary Heart Disease after Coronary Artery Bypass Grafting; Advanced Materials Research : Radiation and nuclear techniques in material science; Vol. 1084 : Physical-Technical Problems of Nuclear Science, Energy Generation, and Power Industry (PTPAI -2014)

Use of {99m}Tc-HMPAO in Evaluating the Results of Cerebral Hypoperfusion Prevention in the Patients with Coronary Heart Disease after Coronary Artery Bypass Grafting; Advanced Materials Research : Radiation and nuclear techniques in material science; Vol. 1084 : Physical-Technical Problems of Nuclear Science, Energy Generation, and Power Industry (PTPAI -2014)

Bibliographic Details
Parent link:Advanced Materials Research : Radiation and nuclear techniques in material science: Scientific Journal
Vol. 1084 : Physical-Technical Problems of Nuclear Science, Energy Generation, and Power Industry (PTPAI -2014).— 2015.— [P. 506-510]
Corporate Author: Национальный исследовательский Томский политехнический университет (ТПУ) Физико-технический институт (ФТИ) Лаборатория № 31 ядерного реактора (Лаборатория № 31 ЯК)
Other Authors: Efimova N. Yu. Nataliya Yurievna, Chernov V. I. Vladimir Ivanovich, Efimova I. Y., Akhmedov S. D., Lishmanov Yu. B. Yury Borisovich
Summary:Title screen
The purpose of this study is to research the use of the radiopharmaceutical {99m}Tc-HMPAO in the evaluation of drug prevention of cerebral complications in patients with coronary heart disease after coronary artery bypass grafting (CABG) performed with cardiopulmonary bypass (CPB). The study included 30 patients, in whom surgical revascularization was performed with CPB. 11 patients in this group were prescribed instenon. All the patients underwent brain tomoscintigraphy with {99m}Tc-HMPAO and neuropsychological testing before CABG and 10-15 days after it. The results showed that {99m}Tc-HMPAO is useful radiopharmaceutical for evaluation of cerebral complications in patients after CABG. Thus, coronary artery bypass grafting using CPB can be complicated by the deterioration of cerebral perfusion and cognitive dysfunction, while preventive medication with instenon can prevent or significantly reduce the violations of cerebral hemodynamics and neuropsychological status of the patients.
Режим доступа: по договору с организацией-держателем ресурса
Language:English
Published: 2015
Series:Radiation Technologies in Medicine
Subjects:
электронный ресурс
труды учёных ТПУ
головной мозг
компьютерная томография
эмиссионная томография
шунтирование
Online Access:http://dx.doi.org/10.4028/www.scientific.net/AMR.1084.506
Format: Electronic Book Chapter
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=640426

Similar Items

Similar Items